Taiwan FDA registration e65c34ca6e92268ad990c19d068200c2
INNO-LIA Syphilis Score
TW: 因諾-立亞梅毒在線免疫分析試劑組
Taiwan·Risk Class 2·MD·FUJIREBIO EUROPE N.V.·Registered Apr 17, 2020 – Apr 17, 2025CancelledRegistration details
- Analysis ID
- e65c34ca6e92268ad990c19d068200c2
- License Form
- Ministry of Health Medical Device Import No. 033472
- Customs Code
- DHA05603347201
Company information
- Manufacturer
- FUJIREBIO EUROPE N.V.
- Manufacturer Country
- Belgium
- Authorized Representative
- Taiwan Fu Pharmaceutical Co., Ltd
Product details
- Product Type (Level 1)
- C Immunology and microbiology devices
- Product Type (Level 2)
- C3830 Treponema pallidum reagent
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Apr 17, 2020
- Expiry Date
- Apr 17, 2025
- Cancellation Date
- Oct 28, 2022
Cancellation information
- Status
- Logged out
- Reason
- 公司歇業
About this record
Access comprehensive regulatory information for INNO-LIA Syphilis Score in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number e65c34ca6e92268ad990c19d068200c2 and manufactured by FUJIREBIO EUROPE N.V.. The authorized representative in Taiwan is Taiwan Fu Pharmaceutical Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices